Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial
Titel:
Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial
Auteur:
Lalazar, Gadi Mizrahi, Meir Turgeman, Ilit Adar, Tomer Ben Ya’acov, Ami Shabat, Yehudit Nimer, Assy Hemed, Nila Zolotarovya, Lidya Lichtenstein, Yoav Lisovoder, Nadya Samira, Sarit Shalit, Itamar Ellis, Ronald Ilan, Yaron